Short interest in Lineage Cell Therapeutics Inc (AMEX:LCTX) increased during the last reporting period, rising from 15.77M to 15.94M. This put 10.89% of the company's publicly available shares short.

Short interest for Lineage Cell Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Lineage Cell Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 447.26K shares traded per day, it would take 35.64 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.